Actively Recruiting
Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners
Led by University Health Network, Toronto · Updated on 2025-12-11
575
Participants Needed
10
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the effectiveness of SHAReClinic, a national, virtual Sexual Health and Rehabilitation eClinic designed to support prostate cancer patients and their partners. Specifically, this study aims to assess SHAReClinic's impact on improving sexual function, satisfaction, and relational intimacy after treatment. The primary objective is to evaluate SHAReClinic's effectiveness across participating sites and determine its role in supporting long-term sexual health and well-being. As part of usual care, newly enrolled SHAReClinic patients will receive guided education modules and access to sexual health counselling at key recovery milestones. SHAReClinic seeks to expand access to sexual health care for prostate cancer patients across Canada by providing evidence-based, virtual sexual rehabilitation. Findings from this study will inform best practices in survivorship care and contribute to the development of a national standard for oncology sexual health interventions.
CONDITIONS
Official Title
Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled for first-line treatment for localized prostate cancer via radical prostatectomy (open or robotic) or radiation treatment (brachytherapy, external beam), alone or with adjuvant androgen deprivation therapy (ADT)
- Patients currently undergoing active treatment for prostate cancer
- Patients who have completed prostate cancer treatment within the past 6 months
- Patients who are hormone and/or chemotherapy-nafve
- Patients aged 18 years or older
- Patients with access to a computer or smartphone with internet access
You will not qualify if you...
- Patients receiving ADT alone as primary treatment or currently on chemotherapy
- Patients who lack proficiency in English
- Patients on nitrate therapy or with contraindications to phosphodiesterase type 5 inhibitors (PDE5i's)
- Patients with medical conditions that make sexual activity unsafe
- Patients who have had previous treatment for prostate cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
Vancouver Coastal Health Authority
Vancouver, British Columbia, Canada, V5Z 1M9
Actively Recruiting
2
Men's Health Clinic Manitoba
Winnipeg, Manitoba, Canada, R3K 1M3
Actively Recruiting
3
Royal Victoria Regional Health Centre
Barrie, Ontario, Canada, L4M 6M2
Actively Recruiting
4
Dianne & Irving Kipnes Urology Centre
Edmonton, Ontario, Canada, T6G 1Z1
Not Yet Recruiting
5
Kingston Health Sciences Centre
Kingston, Ontario, Canada, K7L 2V7
Actively Recruiting
6
St. Joseph's Health Care London
London, Ontario, Canada, N6A 4V2
Not Yet Recruiting
7
Trillium Health Partners
Mississauga, Ontario, Canada, L5A 4G1
Not Yet Recruiting
8
Grass Family Men's Health Center
Ottawa, Ontario, Canada, K1Y 4E9
Actively Recruiting
9
University Health Network
Toronto, Ontario, Canada, M5G 1Z5
Actively Recruiting
10
St. Paul's Hospital
Saskatoon, Saskatchewan, Canada, S7M 0Z9
Not Yet Recruiting
Research Team
S
Steven Guirguis, MA
CONTACT
S
SHC Clinic
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here